- CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26)
Ji-Hea Kim et al, 2023, Heliyon CrossRef - SOX2 Expression Does Not Guarantee Cancer Stem Cell-like Characteristics in Lung Adenocarcinoma
Seung-Hyun Bae et al, 2024, Cells CrossRef - Cut&tag: a powerful epigenetic tool for chromatin profiling
Zhijun Fu et al, 2024, Epigenetics CrossRef - circPDK1 competitively binds miR-4731-5p to mediate GIGYF1 expression and increase paclitaxel sensitivity in non-small cell lung cancer
YunYin Feng et al, 2024, Discover Oncology CrossRef - Application of the Yamanaka Transcription Factors Oct4, Sox2, Klf4, and c-Myc from the Laboratory to the Clinic
Marisol Aguirre et al, 2023, Genes CrossRef - The multifaceted role of SOX2 in breast and lung cancer dynamics
Kiavash Hushmandi et al, 2024, Pathology - Research and Practice CrossRef - miR-199a-5p targets DUSP14 to regulate cell proliferation, invasion and stemness in non-small cell lung cancer
Ying Zheng et al, 2024, Heliyon CrossRef